Literature DB >> 8536364

Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia.

P M Waring1, J Presneill, D W Maher, J E Layton, J Cebon, L J Waring, D Metcalf.   

Abstract

To determine whether circulating levels of any of the colony-stimulating factors (CSF) might contribute to the host response in severe sepsis, plasma concentrations of granulocyte CSF (G-CSF), granulocyte-macrophage CSF (GM-CSF), and macrophage CSF (M-CSF) were measured by immunoassays in 20 subjects with meningococcaemia, a bloodstream infection caused by Neisseria meningitidis, that has proven to be a valuable model to study the responses of other inflammatory mediators during sepsis and septic shock in humans. Plasma G-CSF concentrations were transiently elevated in most subjects during the early phase of meningococcaemia, and were higher in subjects with septic shock (mean +/- s.d. = 165 +/- 142 ng/ml, n = 9) compared with those who remained normotensive (mean +/- s.d. = 7 +/- 2 ng/ml, n = 10) (P < 0.05). Peak plasma G-CSF concentrations > 10 ng/ml were associated with the development of septic shock (P < 0.01), disseminated intravascular coagulation (P < 0.01), fulminant infection (P < 0.05), and a fatal outcome (P < 0.01). Plasma GM-CSF concentrations > 1 ng/ml were briefly present in subjects with life-threatening septic shock (1-15 ng/ml, n = 5), and were strongly associated with fulminant meningococcaemia (P < 0.01). Plasma M-CSF concentrations were marginally elevated in all subjects, but were not associated with complications related to or arising from sepsis-induced organ injury. This study demonstrates that plasma levels of G-CSF, GM-CSF and M-CSF show very different responses during meningococcaemia, changes which presumably reflect the different roles played by these mediators in sepsis and, potentially, in septic shock.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536364      PMCID: PMC1553363          DOI: 10.1111/j.1365-2249.1995.tb03844.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

Review 1.  Molecular physiology of granulocyte-macrophage colony-stimulating factor.

Authors:  J C Gasson
Journal:  Blood       Date:  1991-03-15       Impact factor: 22.113

Review 2.  Inflammatory host responses in sepsis.

Authors:  J J Zimmerman; T V Ringer
Journal:  Crit Care Clin       Date:  1992-01       Impact factor: 3.598

Review 3.  Control of granulocytes and macrophages: molecular, cellular, and clinical aspects.

Authors:  D Metcalf
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

4.  Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome.

Authors:  G Verhoef; M Boogaerts
Journal:  Am J Hematol       Date:  1991-04       Impact factor: 10.047

5.  Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1.

Authors:  I K Campbell; U Novak; J Cebon; J E Layton; J A Hamilton
Journal:  J Immunol       Date:  1991-08-15       Impact factor: 5.422

6.  Levels of serum granulocyte colony-stimulating factor in patients with infections.

Authors:  M Kawakami; H Tsutsumi; T Kumakawa; H Abe; M Hirai; S Kurosawa; M Mori; M Fukushima
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

7.  Distinct in vivo functions of two macrophage subpopulations as evidenced by studies using macrophage-deficient op/op mouse.

Authors:  W Wiktor-Jedrzejczak; A A Ansari; M Szperl; E Urbanowska
Journal:  Eur J Immunol       Date:  1992-07       Impact factor: 5.532

8.  Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs.

Authors:  M Kanazawa; A Ishizaka; N Hasegawa; Y Suzuki; T Yokoyama
Journal:  Am Rev Respir Dis       Date:  1992-05

9.  Endogenous haemopoietic growth factors in neutropenia and infection.

Authors:  J Cebon; J E Layton; D Maher; G Morstyn
Journal:  Br J Haematol       Date:  1994-02       Impact factor: 6.998

10.  Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation.

Authors:  J L Stefano; S Abbasi; S A Pearlman; M L Spear; K L Esterly; V K Bhutani
Journal:  Am Rev Respir Dis       Date:  1991-02
View more
  4 in total

Review 1.  The discovery, development and clinical applications of granulocyte colony-stimulating factor.

Authors:  D C Dale
Journal:  Trans Am Clin Climatol Assoc       Date:  1998

Review 2.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 3.  Emergency granulopoiesis.

Authors:  Markus G Manz; Steffen Boettcher
Journal:  Nat Rev Immunol       Date:  2014-04-22       Impact factor: 53.106

4.  Perioperative recombinant human granulocyte colony-stimulating factor (Filgrastim) treatment prevents immunoinflammatory dysfunction associated with major surgery.

Authors:  Christian Schneider; Sonja von Aulock; Siegfried Zedler; Christian Schinkel; Thomas Hartung; Eugen Faist
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.